Sent on behalf of Brandy Nelson, University of Kentucky Biosafety Officer and Responsible Official: Per the Code of Federal Regulations (7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73) possession, use or transfer of the infectious agents and toxins listed below requires registration with the Centers for Disease Control and Prevention and/or United States Department of Agriculture. Non-compliance with these regulations may result in criminal penalties, including fines and incarceration, affecting the University of Kentucky and/or the individual in possession of the material.

UK HealthCare has been designated a Comprehensive Stroke Center by The Joint Commission (TJC) and the American Heart Association/American Stroke Association.

UK HealthCare is one of 63 U.S. institutions and the only in Lexington to be awarded this designation, which is the highest honor The Joint Commission awards to stroke centers.

stroke_center_designation-19_1_0.jpg
stroke_center_designation-19_1_0.jpg
University of Kentucky College of Medicine student Melanie Pleiss has received the PhRMA Foundation Pre-Doctoral Fellowship in Pharmacology/Toxicology. The fellowship is a two year award that provides recipients with an annual stipend of $20,000 to support the research activities of a doctoral program. "The application process is extremely competitive, with just one applicant per institution allowed to apply and only a certain number of awards given to U.S. schools of medicine, pharmacy, dentistry or veterinary medicine," said Dr.
lab_picture.jpg
lab_picture.jpg
The University of Kentucky Markey Cancer Center has become one of the first cancer centers in the country to offer the latest model of the Varian TrueBeam for its patients. The Varian TrueBeam is an advanced radiotherapy system from Varian Medical Systems, designed to deliver powerful cancer treatments with pinpoint accuracy and precision.
tb-beauty_shot_front-no_couch.jpg
tb-beauty_shot_front-no_couch.jpg

Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2014

For junior faculty with clinical and/or teaching responsibilities, it's difficult to find enough time to prioritize their own research. On top of time constraints, junior faculty members often have limited experience in the precise art of writing successful federal grant applications and managing large grants. It takes time, training, and funding to accelerate a research career. The KL2 Career Development Program provides these resources to investigators to do just that.
fornwalt_vandsburger_leung_uknow1.jpg
fornwalt_vandsburger_leung_uknow1.jpg
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer. Triple-negative breast cancer has an activated EMT program, which is a process that provides cells with the increased plasticity (or flexibility) to adapt to stressed environments during embryonic development, wound healing, tissue fibrosis and metastasis.
zhou.jpg
zhou.jpg

The Office of Sponsored Projects Administration has created a new webpage entitled "Investigator's Survival Guide". This new page offers guidance to investigators at on topics ranging form Proposal Submission to Responsible Conduct of Research. To view the page, click here.

Saha Awards for Cardiovascular Research and Education

Saha Cardiovascular Research Center

2014 Saha Awards

Awards Announcement

The thematic focus of the Center for Molecular Medicine, an NIGMS funded Center of Biomedical Research Excellence (COBRE), is on understanding the molecular basis of human disease. The Center through an NIH/NIGMS P30 grant supports pilot projects and four cores: the Administrative, Protein, Genetic Technologies, and Organic Synthesis cores.  The Protein, Genetic Technologies, and Organic Synthesis cores are run as recharges centers with costs supplementated by the P30 COBRE grant.